HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: A Long Term, Safety Study of Apricitabine in HIV-infected Subjects [Phase 2]
This clinical trial update reports the completion of a Phase 2 long-term safety study of apricitabine in HIV-infected subjects. It summarize…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV [Phase 2]
Phase 2 trial update for AVX754, a new nucleoside reverse transcriptase inhibitor, in drug-resistant HIV; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects [Phase 1]
Phase 1 study evaluating the cardiovascular safety of Apricitabine in healthy volunteers; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together [Phase 1]
Phase 1 pharmacokinetic study evaluating apricitabine and tipranavir when dosed alone and in combination for HIV infection.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans [Phase 1]
Phase 1 clinical trial update evaluating cognitive behavioral therapy to reduce binge drinking and alcohol use among HIV-infected individual…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-20Clinical Trial Update: Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa [Phase 2]
A Phase 2 pharmacokinetics study evaluating rifabutin when combined with antiretroviral therapy in TB/HIV co-infected patients in South Afri…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Clinical trial BRAVO studied a background regimen including raltegravir for HIV; the trial is completed and results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities [NA]
Completed clinical trial in resource-limited South African communities comparing two anti-HIV treatment strategies; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers [Phase 1, Phase 2]
A Phase 1/2 study evaluating the safety and immunogenicity of a candidate HIV-1 vaccine administered to healthy infants born to HIV-1-infect…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. [Phase 3]
Phase III study TMC125-C216 evaluates etravirine (TMC125) as part of an antiretroviral regimen including TMC114/ritonavir in HIV-1 infected …
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV. [Phase 2]
This Phase II trial update reports the completion of a randomized, partially blinded dose-response study of darunavir/ritonavir in 3-class e…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) [Phase 4]
Phase 4 study evaluating tuberculosis preventive therapy in people with HIV on HAART has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a plus ribavirin for treating Hepatitis C in HIV-infected patients completed, with resul…
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy [Phase 3]
Phase 3 trial of NGX-4010 (capsaicin 8% patch) for painful HIV-associated neuropathy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers [Phase 2]
Phase IIa trial evaluating the safety and immunogenicity of a DNA HIV-1 vaccine followed by an MVA HIV-1 vaccine in HIV-uninfected volunteer…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options [Phase 3]
Phase 3 study assessing safety of TMC114 (darunavir) boosted with low-dose ritonavir in experienced HIV-1 infected patients with limited or …
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients
This completed trial reports on the prevalence and determinants of COPD in HIV-positive patients.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients [Phase 2]
A Phase 2 trial comparing PROCRIT (epoetin alfa) dosing every two weeks versus once weekly in anemic HIV-infected patients; the study was te…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. [Phase 1]
A Phase I, open-label trial evaluated the pharmacokinetic interaction between TMC125 (etravirine) and the antifungal agents fluconazole and …
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet [Phase 1]
Phase 1 bioavailability and pharmacokinetics study comparing the pediatric suspension formulation of darunavir to the current tablet was com…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation [Phase 1]
Phase 1 bioavailability study in healthy adult volunteers evaluating three pediatric formulations of TMC278 (rilpivirine) against the adult …
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus [Phase 1]
Phase 1 repeat-dose trial of bavituximab in patients co-infected with hepatitis C and HIV has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers. [Phase 1]
This completed Phase I study evaluated the pharmacokinetic interaction between lopinavir/ritonavir and TMC125 (rilpivirine) in healthy volun…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy. [Phase 1]
Phase I open-label trial to assess pharmacokinetic interaction between TMC125 (etravirine) and buprenorphine/naloxone in HIV-negative patien…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Safety and Efficacy of T Cell Genetic Immunotherapy for HIV [Phase 2]
A Phase 2 trial update from VIRxSYS Corporation evaluating the safety and efficacy of a T cell genetic immunotherapy for HIV.